LP-184 Rationale and design of two phase 3, Randomized, double-blind, placebo-controlled studies of the efficacy and safety of litifilimab in adults with active systemic lupus erythematosus: TOPAZ-1 and TOPAZ-2

Subjects

Subjects :

Immunologic diseases. Allergy
RC581-607

Details

Language :

English

ISSN :

20538790

Volume :

10

Issue :

Suppl 1

Database :

Directory of Open Access Journals

Journal :

Lupus Science and Medicine

Publication Type :

Academic Journal

Accession number :

edsdoj.71bd13800bc45c286783812a02c3023

Document Type :

article

Full Text :

https://doi.org/10.1136/lupus-2023-KCR.259